3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Thrombosis
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Recurrence
2
Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Disease
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombophilia
1
Thrombocytopenia
1
Thoracic Neoplasms
1
Skin Neoplasms
1
Pituitary Neoplasms
1
Pediatric Solid Tumor, Unspecified, Protocol Specific
1
Papillomavirus Infections
1
Interventions
Bevacizumab
3
napabucasin
2
Leucovorin
2
Irinotecan
2
Gemcitabine
2
Fluorouracil
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
linifanib
1
enoxaparin sodium
1
encorafenib
1
Surveys and Questionnaires
1
Sorafenib
1
Oxaliplatin
1
Oviposition
1
Levoleucovorin
1
Injections
1
Hydromorphone
1
Fentanyl
1
Drug Therapy
1
Drainage
1
Dalteparin
1
Cetuximab
1
Capecitabine
1
Bupivacaine
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Digestive System Diseases
×
Injections
×
Clear all
NCT06153394
2024-04-23
PRIORITY
Western University, Canada
Phase 3
Not yet recruiting
50 enrolled